How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?

J Antimicrob Chemother. 2018 Aug 1;73(8):2271-2273. doi: 10.1093/jac/dky139.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Anti-Retroviral Agents / administration & dosage
  • Anti-Retroviral Agents / pharmacology*
  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / pharmacology*
  • Cobicistat / administration & dosage
  • Cobicistat / pharmacology
  • Drug Interactions*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Ritonavir / administration & dosage
  • Ritonavir / pharmacology

Substances

  • Anti-Retroviral Agents
  • Calcium Channel Blockers
  • Cobicistat
  • Ritonavir